A phase II trial investigating a twice weekly administration of the oral taxane BMS-275183 in patients with NSCLC [non-small cell lung cancer]
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2006
At a glance
- Drugs BMS 275183 (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 15 Feb 2006 New trial record.